商品介绍
ABT-263(Navitoclax)isapotentinhibitorofBcl-xL,Bcl-2andBcl-wwithKi~0.5nM,1nMand1nMincell-freeassays.ABT-263blockstheBcl-2/Bcl-xLinteractions,therebypromotingapoptosis.
AdditionalInformation
| ProductName: | ABT-263(Navitoclax) |
|---|---|
| AlsoKnownAs: | 4-[4-[[2-(4-chlorophenyl)-5,5-dimethyl-1-cyclohexen-1-yl]methyl]-1-piperazinyl]-N-[[4-[[(1R)-3-(4-morpholinyl)-1-[(phenylthio)methyl]propyl]amino]-3-[(trifluoromethyl)sulfonyl]phenyl]sulfonyl]-benzamide |
| CatalogNo.: | F7140 |
| Size: | 5mg |
| CAS: | N/A |
| Formula: | C47H55ClF3O6S3 |
| MolecularWeight: | 974.61Da |
| Form: | Lyophilizedpowder |
| QualityAssurance: | >98%byHPLCandNMR |
| Source: | Synthetic |
| Storage: | EligIBLeforroomtemperatureshipping.Storeat-80°Cuponreceiving |
| PDFDataSheet: | DownloadPDFdatasheet |
| Image(s): | N/A |
| ShippingMethod: | Roomtemperatureshipping |
| References: | TseC,etal.(2008)CancerRes.68(9),3421-3428. |
